SoylentNews

takyon [soylentnews.org] writes:

Uh oh, a biotechnology company's shares are spiking [cnbc.com]! Illumina [wikipedia.org], a company that makes DNA sequencing machines, has announced the NovaSeq, a sequencer it expects to enable $100 genome sequencing (some day) [techcrunch.com]:

Illumina's CEO Francis deSouza showed off the machine, called the NovaSeq, onstage at the JP Morgan Healthcare Conference in downtown San Francisco today, telling the crowd the machine's scanning speed could decipher an entire human genome in less than an hour. [...] Illumina's new machine is meant to be a lower-priced device and comes in two models — NovaSeq 5000 for $850,000 and the NovaSeq 6000 for $985,000.

Six customers have already come on board to test NovaSeq, including the Chan Zuckerberg Biohub (the life sciences arm started by Mark Zuckerberg and his wife Priscilla Chan), the Broad Institute of MIT and Harvard and biotech companies Regeneron and Human Longevity Inc. DeSouza also confirmed each company had put in a purchase order for the new machine.

Here's the company's press release [illumina.com], and some related information at Next Big Future [nextbigfuture.com].

Original Submission